Kioson Komersial Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kioson Komersial Indonesia Tbk trades at Rp93 (market cap 102.21B, 5.93M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 45.9K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kioson Komersial Indonesia Tbk is more actively traded (5.93M versus 45.9K). Which is the better fit depends on your goals.
| KIOS | OBAT | |
|---|---|---|
Market Cap | 102.21B | 164.65B |
Volume | 5.93M | 45.9K |
Lot | 59.28K | 459 |
Turnover | 550.68M | 11.08M |
Average Price | 92.9 | 241.33 |
Value | 550.68M | 11.08M |
Indicative Equilibrium Price | 96 | 238 |
Indicative Equilibrium Volume | 1.14K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.
Read more on KIOS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →